This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


Advertisement


 Mobile version  RSS  Subscribe  Unsubscribe  Archive  Media Kit

Home   About AST   Education   Meetings & Events   Public Policy   Contact Us   Aug. 16, 2013


Advertisement

Advertisement

Advertisement
 

Advertisement

Social media and organ donor registration: The Facebook effect
American Journal of Transplantation
Despite countless media campaigns, organ donation rates in the United States have remained static while need has risen dramatically. New efforts to increase organ donation through public education are necessary to address the waiting list of over 100,000 patients. On May 1, 2012, the online social network, Facebook, altered its platform to allow members to specify "Organ Donor" as part of their profile. Upon such choice, members were offered a link to their state registry to complete an official designation, and their "friends" in the network were made aware of the new status as a donor. Educational links regarding donation were offered to those considering the new organ donor status.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Advertisement


SOCIETY NEWS


Tickets are on sale for the Power2Save concert featuring The Band Perry!
Upgrade your concert experience while giving to Power2Save. This limited quantity, special ticket package is $250 and is only available on the P2S website! This package includes:
  • Premium seating (choice of floor seat or padded premium seat in elevated section)
  • Access to an exclusive pre-concert reception with food and beverages
  • 1 signed copy of The Band Perry's new CD Pioneer
  • A contribution of $140 toward the Power2Save initiative
Buy your ticket now! Can't attend the concert? Make a donation to Power2Save.

All donations go toward the Power2Save mission, which is dedicated to increasing public awareness of the importance of donating organs, advocating for patient health and funding transplant research through the Transplant Research Institute.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Wanted: Your nominations for the 2014 AST Board
AST
Dr. Roslyn Mannon, chair of the AST Governance Committee, invites AST members to submit nominations for qualified individuals to serve on the AST Board of Directors. Open positions include eresident-elect (one year term), treasurer (two year term), and three councilors-at-large (three year terms each). Read the official announcement here.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Advertisement
PRODUCT SHOWCASE
  University of Utah - Multi-Organ Transplant Surgeon
The University Of Utah Department Of Surgery is seeking applications for a faculty member to join the multi-organ transplant team at the assistant professor level. This is an opportunity to join an expanding program and a cohesive group of transplant surgeons focused on excellence. The candidate should be board certified in general surgery and have completed an ASTS approved transplantation surgery fellowship. Apply here
 


Attend the AST's Cutting Edge of Transplantation 2014
Come to Arizona next February for the AST's Cutting Edge of Transplantation where expert clinicians, leading diagnosticians and world class scientists will address this enormous challenge together with an engaged audience. Topics include: Organ preservation and injury prevention, chronic injury and tolerance, immunosuppression, inflammation and fibrosis as targets, microbiomes, senescence and omics in the clinic. Abstract submission will open soon!

When: Feb. 13-16, 2014
Where: Sheraton Wild Horse Pass, Chandler, Ariz.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Support federal research funding for NIH and medical research
AST
The AST's Public Policy Committee and Washington, D.C., Government Relations office continue to meet daily with Congressional decision-makers on Capitol Hill in support of $32 billion for FY 2014. This is the agreed upon figure that the national research community has collectively been requesting for this upcoming fiscal year. Please take a moment to let your U.S. Senators and House Representative know that you are aware, watching and feeling the direct effects of inadequate federal funding for NIH and medical research in your local institution and home state.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Featured Advertisers


Advertisement


Astellas is entering its 20th year focusing on transplant immunology. Today we remain steadfast in our commitment to advancing the field. Tomorrow we will seek new possibilities to help improve the transplant experience. Together. Please visit astellas.us
Advertisement
University of Vermont Transplant Nephrologist

The University of Vermont/Fletcher Allen Health Care is seeking applications for a senior faculty member to join the Division of Nephrology. The candidate should be UNOS certified in kidney and pancreas transplants, experienced in educating nephrology fellows, growing transplant programs, and providing administrative leadership. Apply Here
Amnis
The FlowSight offers high performance in a small package. Its innovative design increases signal and minimizes noise to provide unmatched fluorescence sensitivity. Twelve standard detection channels simultaneously produce brightfield, darkfield and up to ten channels of fluorescence imagery of every cell. More info


TRANSPLANT NEWS


Astellas receives FDA approval for a new product
Astellas
The U.S. Food and Drug Administration (FDA) recently approved the New Drug Application (NDA) for ASTAGRAF XL™ (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab induction. Read the full press release here.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Mechanical circulatory support and heart transplantation: Donor and recipient factors influencing graft survival.
NCBI
Mechanical circulatory support is an accepted strategy to bridge patients to heart transplantation (HTx). Among mechanical circulatory support patients who go on to HTx, factors associated with improved graft survival have not been fully elucidated.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    The effect of donor-recipient gender mismatch on short- and long-term graft survival in kidney transplantation (Clinical Transplantation)
Focal segmental glomerulosclerosis in children: Multivariate analysis indicates that donor type does not alter recurrence risk (Transplantation)
Cytomegalovirus prophylaxis in pediatric kidney transplantation: The Dutch experience (Pediatric Transplantation)
SOS Liver damage; calling all haematopoietic stem cells (Liver International)

Don't be left behind. Click here to see what else you missed.


Current role of human leukocyte antigen matching in kidney transplantation
NCBI
With graft survival rates steadily improving during the recent years, there is debate whether donor kidneys should still be allocated according to compatibility for human leukocyte antigens (HLA). Recent studies argue for continued kidney exchange efforts for achieving better HLA compatibility. In this modern era of immunosuppression, better HLA matching is associated not only with better graft survival, but also with the administration of lower dosages of immunosuppressive agents, a lower incidence of side-effects of immunosuppression such as non-Hodgkin lymphoma, hip fractures and death from infection, and a lower grade of sensitization if a patient has lost a kidney graft and is relisted for a retransplant.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


OPTN to implement new process for patient status verification
HRSA
UNOS Data Quality has introduced a new process for verifying with transplant programs the current status (living or dead) of certain candidates waitlisted and recipients transplanted and/or followed post-transplant at the transplant program. This process involves use of data from other sources to supplement patient status information known to the transplant program. Information in some of these sources must be confirmed before being incorporated in the OPTN database. UNOS will contact the designated Primary Program Administrator and Primary Data Coordinator at the applicable transplant programs by secure email and will provide relevant information for each patient, as well as instructions for making the updates. Click here for additional detail on the OPTN website.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Featured Advertisers


Advertisement
Put Science on Your Side

Drug Monitoring Platforms since 1981.

Learn More
Advertisement
Exclusively Focused Transplant Pharmacy Therapeutics
Transplant IV Biologics and Oral Immunosuppressives specializing in Desensitization and AMR Treatment and Prevention. MORE


Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation
NCBI (login required)
Preformed donor-specific human leukocyte antigen antibodies (DSAs) are considered a contraindication to the transplantation of most solid organs other than the liver. Conflicting data currently exist on the importance of preformed DSAs in rejection and patient survival after liver transplantation (LT). To evaluate preformed DSAs in LT, researchers retrospectively analyzed prospectively collected samples from all adult recipients of primary LT without another organ from January 1, 2000 to May 31, 2009 with a pre-LT sample available (95.8 percent of the patients).
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Using implantation biopsies as a surrogate to evaluate selection criteria for living kidney donors
Transplantation (login required)
The acceptance criteria used for living kidney donors are largely theoretical, as they are not clearly linked to outcomes. The goal of this study was to use implantation biopsies as a surrogate outcome marker to evaluate our living kidney donor selection criteria.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Factors limiting organ donation in Baden-Württemberg
Clinical Transplantation (login required)
In the German state of Baden-Württemberg, the number of deceased donors from whom organs have been recovered has been decreasing over the past several years. It has been questioned whether changing donor age and/or cause of death (COD) were contributing to this trend.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Courtney Hodges, Content Editor, 972.402.2604   
Contribute news


This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
Aug. 9, 2013
August 2, 2013
July 26, 2013
July 19, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063